Discover 3,622 paid clinical trials in Orange County, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Orange County offers clinical trials for a variety of conditions, including high blood pressure, heart disease, and skin disorders such as eczema, alopecia, and psoriasis. The city’s medical institutions are actively recruiting both healthy volunteers, as well as those with specific health needs to participate in studies that could improve treatments and outcomes for these, and many other widespread health issues.
Filter
2
Filter results
Results: 3,622
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
for
Chronic Graft-versus-host-disease
Location: Duarte CA, Los Angeles CA, La Jolla CA,
Sponsor: Incyte Corporation
Sex: All
Age: 12+
Code: NCT06585774
Phase 3, Recruiting
Telemedicine for Improvement of Care for Older Adults With Cancer in the Underserved Community, The GAIN-S Trial
for
Hematopoietic and Lymphoid System Neoplasm,
Location: Duarte CA, Upland CA, Lancaster CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 65+
Code: NCT06022965
Recruiting
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
for
Small Cell Lung Cancer (SCLC),
Location: Duarte CA, Los Angeles CA, Portland OR, Seattle WA,
Sponsor: Phanes Therapeutics
Sex: All
Age: 18+
Code: NCT05652686
Phase 1, Phase 2, Recruiting
A First-in-human (FIH), Phase I Study of PTX-912 in Patients with Locally Advanced/Metastatic Solid Tumors
for
Advanced Cancer, Solid Tumor, Metastatic Cancer
Location: Duarte CA, Omaha NE, Miami FL
Sponsor: Proviva Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06190886
Phase 1, Recruiting
Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas
for
Follicular Helper T-Cell Lymphoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT07278856
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Papaverine in Combination With Radiation Therapy for the Treatment of Locally Advanced Rectal Cancer, DINOMITE Trial
for
Locally Advanced Rectal Adenocarcinoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT06834126
Phase 1, Recruiting
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
for
PIK3CA Mutations, Advanced Solid Tumors, Adult,
Location: Los Angeles CA, Scottsdale AZ, Palo Alto CA,
Sponsor: Cogent Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT07383506
Phase 1, Recruiting
A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
for
Acute Myeloid Leukemia, Myelodysplastic Syndromes
Location: Duarte CA, Kansas City KS, New York NY
Sponsor: GluBio Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06146257
Phase 1, Recruiting
Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer
for
Platinum-Resistant Ovarian Carcinoma
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: Female
Age: 18+
Code: NCT05225363
Phase 1, Recruiting
Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
Location: Fullerton CA, Bakersfield CA, Phoenix AZ,
Sponsor: Adverum Biotechnologies, Inc.
Sex: All
Age: 50+
Code: NCT07630649
Phase 2, Recruiting
PEACE Trial: Postpartum Evaluation of Antihypertensive Cessation and Efficacy
for
Postpartum Hypertension (PPHT)
Location: Los Angeles CA
Sponsor: University of California, Los Angeles
Sex: Female
Age: 18 - 64
Code: NCT06915792
Recruiting
A Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-thymocyte Globulin) Followed by Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Patients With Refractory or Recurrent Severe Aplastic Anemia
for
Recurrent Severe Aplastic Anemia,
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 0 - 70+
Code: NCT05757310
Phase 1, Recruiting
An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED
for
Persistent Corneal Epithelial Defect
Location: Huntington Beach CA, Laguna Hills CA, Redlands CA,
Sponsor: Dompé Farmaceutici S.p.A
Sex: All
Age: 18+
Code: NCT07519902
Phase 3, Recruiting
A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer
for
Triple Negative Breast Cancer
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: Female
Age: 18+
Code: NCT05989828
Phase 1, Recruiting
Study of Aritinercept in Patients With Generalized Myasthenia Gravis
for
Myasthenia Gravis, Generalized
Location: Pasadena CA, Houston TX, O'Fallon IL, Chicago IL,
Sponsor: Aurinia Pharmaceuticals Inc.
Sex: All
Age: 18 - 70+
Code: NCT07596901
Phase 1, Phase 2, Recruiting
Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica
for
Polymyalgia Rheumatica
Location: Tustin CA, Huntington Beach CA, Covina CA, Temecula CA,
Sponsor: Sanofi
Sex: All
Age: 50+
Code: NCT07286214
Phase 3, Recruiting
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
for
Pulmonary Hypertension Due to Lung Disease (Disorder)
Location: Los Angeles CA, Phoenix AZ, Scottsdale AZ,
Sponsor: Liquidia Technologies, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07285655
Phase 3, Recruiting
Early Onset Colorectal Cancer Detection
for
Colorectal Cancer, Colorectal Neoplasms,
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18 - 50
Code: NCT06342401
Recruiting
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
for
Colitis, Ulcerative, Crohn Disease
Location: Los Angeles CA, Oxnard CA, Las Vegas NV, Englewood CO,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07483073
Phase 2, Recruiting
Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial